Who owns Doshi Dipal?

No ownership or control links for Doshi Dipal are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Doshi Dipal's risk level?

WhiteIntel flags Doshi Dipal as medium risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Doshi Dipal appear across sources?

Doshi Dipal is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

PersonMedium

Doshi Dipal

Name: Doshi Dipal — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Doshi Dipal, Person, US

Doshi Dipal — US person (sec:0001613084). 7 holdings. Every claim linked to its source.

controls 7 companies

Ownership graph Export .md

JSON / MCPsample

The finding

Controls or directs 7 companies in the resolved graph.

Investigative lead by resolved identity, not a legal determination.

/01

Registry identity

Controls: 7 companies
Risk: Medium
Jurisdiction: US

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies

Doshi Dipal
- Entrada Therapeutics, Inc.· officer· via SEC EDGAR (Form 3/4/5)
- Azenta, Inc.· director· via SEC EDGAR (Form 3/4/5)
- AMICUS THERAPEUTICS, INC.· officer· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for Doshi Dipal — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of Doshi Dipal is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, nationality & aliases
Sanctions, PEP & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on Doshi Dipal is behind a paywall — everything we hold on this subject is already on this page.

/03

People & control

3 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
AMICUS THERAPEUTICS, INC.
Also holds roles at 112 other companies
- Campbell Bradley Lofficer
- Prout Samanthaofficer
- Castelli Jeffofficer
●
Azenta, Inc.
Also holds roles at 82 other companies
- Lin Lawrence Y.officer
- Koffey Quentindirector
- Madaus Martin Ddirector
●
Entrada Therapeutics, Inc.
Also holds roles at 42 other companies
- WENTWORTH KORY JAMESofficer
- Dowden Nathan Jofficer
- Sethuraman Natarajanofficer

3 parties · 0 current. Ceased and resigned records are retained as history.

/04

Common questions

Who owns Doshi Dipal?: No ownership or control links for Doshi Dipal are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is Doshi Dipal's risk level?: WhiteIntel flags Doshi Dipal as medium risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Doshi Dipal appear across sources?: Doshi Dipal is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Doshi Dipal. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…